Avantor, Inc. (AVTR) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$16.43

From 52W high−0.79%

Volume9.31M

Market cap$11.02B

P/E (TTM)—

P/S (TTM)1.7x

Div yield—

Key dataOct 19, 2026

Open

$16.43

From 52W high

−0.79%

Volume

9.31M

Market cap

$11.02B

ValuationView details →

P/E (Fwd)

18.6x

EV/EBITDA

115.0x

P/E (TTM)

—

RSI (14)

64.7

MomentumView details →

1D Return

−0.79%

YTD Return

+41.80%

SummaryUpdated Jun 1, 2026

Avantor, Inc. (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the life sciences and advanced technology industries. Founded in 1904 and headquartered in Radnor, Pennsylvania, the company went public in May 2019. Avantor serves customers across biopharma, healthcare, education and government, advanced technologies, and applied materials industries worldwide. The company has evolved from its origins as a specialty chemicals provider into a comprehensive solutions partner for organizations conducting critical research, development, and production activities.

Ask drillr about Avantor, Inc. →

ValuationView details →

P/E (Fwd)

18.6x

P/E (TTM)

—

EV/EBITDA

115.0x

EV/Sales

2.2x

P/S (TTM)

1.7x

P/B (TTM)

2.0x

ProfitabilityView details →

Gross Margin

31.83%

Net Margin

−8.81%

EBITDA Margin

1.91%

ROE (TTM)

−10.27%

ROA (TTM)

−4.98%

Asset Turnover

0.56x

GrowthView details →

Revenue YoY

−1.57%

EPS YoY

—

FCF YoY

−18.20%

Revenue CAGR 3Y

−4.46%

EPS CAGR 3Y

—

EBITDA YoY

−91.12%

MomentumView details →

1D Return

−0.79%

YTD Return

+41.80%

1Y Return

+7.05%

RSI (14)

64.7

vs 50D SMA

+8.87%

vs 200D SMA

+47.99%

Capital & dividendView details →

Debt/Equity

0.66x

Current Ratio

1.78x

Quick Ratio

1.18x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.21

EPS Surprise

9.37%

Beats (12Q)

8/12

Next Q EPS Est

$0.22

Avg Surprise (4Q)

4.14%

Rev Surprise

4.94%

Financials snapshotView financials →

Revenue (TTM)

6.56B

Net Income (TTM)

−578.00M

Op. CF (TTM)

597.00M

Next earningsOct 28, 2026 →

Latest newsMore news →

AbbVie appointed John M. Carethers as a Class II director, effective October 14, 2026.4d ago

Avantor, Inc. announced it will release its third quarter 2026 financial results before market open on October 28, 2026, and hold a conference call the same day.19d ago

Similar companies

The Cooper Companies, Inc.COO Repligen CorporationRGEN 海泰新光688677.SH Masimo CorporationMASI Baxter International Inc.BAX Angelalign Technology Inc.06699.HK Find similar companies →

Latest newsMore news →

AbbVie appointed John M. Carethers as a Class II director, effective October 14, 2026.4d ago Avantor, Inc. announced it will release its third quarter 2026 financial results before market open on October 28, 2026, and hold a conference call the same day.19d ago